UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-A

 

 

 

For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or 12(g) of the
Securities Exchange Act

 

Foamix Pharmaceuticals Ltd.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

 

Israel 

(State or other jurisdiction of incorporation) 

Not Applicable 

(IRS Employer Identification No.) 

   

2 Holzman Street , Weizmann Science Park  

Rehovot, 76704, Israel   

(Address of principal executive offices)  

 

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class
to be so Registered 

 

Name of Each Exchange on which
Each Class is to be Registered  

Ordinary Shares, par value NIS 0.16 per share The NASDAQ Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. o

 

Securities Act registration statement file number to which this form relates: 333-198123

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 
 

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1: Description of Registrant's Securities to be Registered

 

The description under the heading “Description of Share Capital” relating to the Registrant's Ordinary Shares par value NIS 0.16 per share (the “Ordinary Shares”), included in the Registrant's Registration Statement on Form F-1 (Registration No. 333-198123), as amended from time to time (the “Registration Statement”) filed with the Securities and Exchange Commission, is incorporated herein by reference. The final prospectus will be filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, and, upon filing, shall be deemed to be incorporated herein by reference.

 

Item 2: Exhibits

 

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are quoted on the NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 
 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Foamix Pharmaceuticals Ltd.
  (Registrant)
   
Dated: September 15, 2014 By: /s/ Dov Tamarkin
  Name: Dov Tamarkin
  Title: Chief Executive Officer